Clinical Trials Directory

Trials / Completed

CompletedNCT05702892

Evaluation of Bone Metabolism Biomarkers in Periodontal Diseases

Evaluation Of Biomarkers Associated With Bone Metabolism İn Patients With Different Periodontal Status

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Necmettin Erbakan University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study evaluates the levels of biomarkers associated with bone metabolism in patients with different periodontal conditions.

Detailed description

Background: In this study, the levels of bone metabolism markers found in the saliva of individuals with different periodontal conditions were compared and the relationship of these markers with periodontal status was examined. Method: A total of 60 individuals, 20 with periodontitis (P), 20 with gingivitis (G), and 20 with periodontal healthy (S), were included in the study. Periodontal clinical parameters (plaque index, gingival index, bleeding on probing, clinical attachment level and probing pocket depth) and saliva samples were obtained from the individuals. Bone metabolism biomarker (necrotizing factor (TNF)-α, osteoprotegerin (OPG), nuclear factor kappa-β receptor activator ligand (RANKL) and sclerostin) levels in saliva samples were evaluated by enzyme-linked immunosorbent assay (ELISA).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTELISAELISA(enzyme-linked immunosorbent assay)

Timeline

Start date
2020-11-05
Primary completion
2021-05-05
Completion
2021-11-05
First posted
2023-01-27
Last updated
2023-01-27

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05702892. Inclusion in this directory is not an endorsement.